Vaxess Technologies
Drug DeliveryWebsite
Vaxess Technologies valuation and funding history | Last updated: August 27, 2025 | 4 funding rounds
Current Valuation
N/A
As of August 27, 2025
Total Funding Raised
$86.2M
Across 4 rounds
Last Round
Later Stage VC
$7.9M
Last Funding
Aug 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| April 9, 2025 | Later Stage VC | $9.0M | N/A | - |
| May 16, 2024 | Later Stage VC | $12.0M | N/A | - |
| July 17, 2023 | Later Stage VC (Series B1) | $11.1M | N/A | - |
| January 10, 2023 | Later Stage VC (Series B) | $37.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Vaxess Technologies is currently valued at N/A as of August 27, 2025. The company has raised a total of $86.2M in funding across 4 funding rounds.
What is Vaxess Technologies Worth in 2026?
Vaxess Technologies is a leading private company in the Drug Delivery sector. Track Vaxess Technologies's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Vaxess Technologies Valuation is Determined
Private company valuations like Vaxess Technologies's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.